Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Verve Therapeutics, Inc. has filed 344 SEC EDGAR filings since 22 Jan 2021

SEC filing history

Showing 1-25 of 344 matching filings.

Per page
25
Current page
1
SCHEDULE 13G File 005-92605

SCHEDULE 13G filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92605

SCHEDULE 13G/A filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12G File 001-40489

15-12G

Filing date
04 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-267578

EFFECT filing

Filing date
28 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-92605

SCHEDULE 13G/A filing

Filing date
28 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-267578

POS AM

Filing date
25 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-267578

POSASR

Filing date
25 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-285309

S-8 POS

Filing date
25 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-277385

S-8 POS

Filing date
25 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .